Siteman Receives $100,000 Gift From Harrah's

 
 
 Harrah's gift.jpg
From left, Siteman Cancer Center director Timothy Eberlein, MD, accepts a $100,000 gift from Harrah’s representatives Bob Mast, Jill Thurman, Jonathan Tilghman and Greg Hinton.
Jan. 30, 2008 – In support of the greater St. Louis community, the Harrah’s Foundation has made a two-year, $100,000 grant to the Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine for its Program for the Elimination of Cancer Disparities (PECaD). The grant will focus on breast and prostate cancer.

PECaD was established to address racial, ethnic, gender and income disparities in the prevention, diagnosis and treatment of cancer. A key goal of the program is to enhance access to cancer screening, particularly among minority and indigent populations at high risk for breast and prostate cancer. Sixty percent of the Harrah's gift will be allocated for breast cancer efforts, and 40 percent will go toward prostate cancer initiatives.

“We are incredibly appreciative of this gift from Harrah’s,” says Timothy Eberlein, MD, Siteman Cancer Center director. “PECaD is an example of what sets Siteman apart from other institutions as a National Cancer Institute-designated Comprehensive Cancer Center. This gift will help us expand our outreach programs and their impact on the St. Louis area.”

The Harrah’s Foundation provides financial support to qualified organizations in communities where Harrah’s employees live and work. Since its formation in 2002, the foundation has committed nearly $60 million to nonprofit groups throughout the United States.